Keloids: Clinical Trials

2 trials for Keloids, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Terminated 2

Follow Keloids: new trials by email Literature Review of Keloids trials Research Report on Keloids

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sorafenib for Patients With Extensive Keloids
Sorafenib - Keloids
Phase 2TerminatedTirgan, Michael H., M.D.602013-03-012016-10-18
Efficacy 2 Part Study of Identification of Keloid Biomarkers and Effect of QAX576 on Keloid Recurrence
QAX576, QAX576 placebo - Keloids
Phase 2TerminatedNovartis Pharmaceuticals32009-06-012020-12-19

Narrower conditions

Keloid (2)  ·  Recurrence (1)

Broader conditions

Cicatrix (2)  ·  Collagen Diseases (2)  ·  Connective Tissue Diseases (2)  ·  Fibrosis (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Skin and Connective Tissue Diseases (2)  ·  Disease Attributes (1)

Interventions

Sorafenib (1)

Sponsors

Novartis Pharmaceuticals (1)  ·  Tirgan, Michael H., M.D. (1)

Countries

United States (2)

Top investigators

Michael H Tirgan, MD (1)